Lack of association of rare functional variants in TSC1/TSC2 genes with autism spectrum disorder

被引:14
|
作者
Bahl, Samira [1 ]
Chiang, Colby [1 ]
Beauchamp, Roberta L. [1 ]
Neale, Benjamin M. [1 ,2 ,3 ]
Daly, Mark J. [1 ,2 ,3 ]
Gusella, James F. [1 ,3 ,4 ]
Talkowski, Michael E. [1 ,3 ]
Ramesh, Vijaya [1 ]
机构
[1] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA
[3] Broad Inst, Program Med & Populat Genet, Cambridge, MA 02143 USA
[4] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA
来源
MOLECULAR AUTISM | 2013年 / 4卷
关键词
Autism spectrum disorder; Tuberous sclerosis complex; Mammalian target of rapamycin; Next-generation sequencing; Rare variants; DE-NOVO MUTATIONS; COMPLEX; LIGASE; INDIVIDUALS; TSC1; RHEB; PAM; PLASTICITY; FRAMEWORK; REVEALS;
D O I
10.1186/2040-2392-4-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Autism spectrum disorder (ASD) is reported in 30 to 60% of patients with tuberous sclerosis complex (TSC) but shared genetic mechanisms that exist between TSC-associated ASD and idiopathic ASD have yet to be determined. Through the small G-protein Rheb, the TSC proteins, hamartin and tuberin, negatively regulate mammalian target of rapamycin complex 1 (mTORC1) signaling. It is well established that mTORC1 plays a pivotal role in neuronal translation and connectivity, so dysregulation of mTORC1 signaling could be a common feature in many ASDs. Pam, an E3 ubiquitin ligase, binds to TSC proteins and regulates mTORC1 signaling in the CNS, and the FBXO45-Pam ubiquitin ligase complex plays an essential role in neurodevelopment by regulating synapse formation and growth. Since mounting evidence has established autism as a disorder of the synapses, we tested whether rare genetic variants in TSC1, TSC2, MYCBP2, RHEB and FBXO45, genes that regulate mTORC1 signaling and/ or play a role in synapse development and function, contribute to the pathogenesis of idiopathic ASD. Methods: Exons and splice junctions of TSC1, TSC2, MYCBP2, RHEB and FBXO45 were resequenced for 300 ASD trios from the Simons Simplex Collection (SSC) using a pooled PCR amplification and next-generation sequencing strategy, targeted to the discovery of deleterious coding variation. These detected, potentially functional, variants were confirmed by Sanger sequencing of the individual samples comprising the pools in which they were identified. Results: We identified a total of 23 missense variants in MYCBP2, TSC1 and TSC2. These variants exhibited a near equal distribution between the proband and parental pools, with no statistical excess in ASD cases (P > 0.05). All proband variants were inherited. No putative deleterious variants were confirmed in RHEB and FBXO45. Three intronic variants, identified as potential splice defects in MYCBP2 did not show aberrant splicing upon RNA assay. Overall, we did not find an over-representation of ASD causal variants in the genes studied to support them as contributors to autism susceptibility. Conclusions: We did not observe an enrichment of rare functional variants in TSC1 and TSC2 genes in our sample set of 300 trios.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Molecular analysis of the TSC1 and TSC2 tumour suppressor genes in sporadic glial and glioneuronal tumours
    Parry, L
    Maynard, JH
    Patel, A
    Hodges, AK
    von Deimling, A
    Sampson, JR
    Cheadle, JP
    HUMAN GENETICS, 2000, 107 (04) : 350 - 356
  • [42] Mutation screening of TSC1 and TSC2 genes in Chinese Han children with tuberous sclerosis complex
    Mi, C. R.
    Wang, H.
    Jiang, H.
    Sun, R. P.
    Wang, G. X.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (01) : 2102 - 2106
  • [43] Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece
    Avgeris, Socratis
    Fostira, Florentia
    Vagena, Andromachi
    Ninios, Yiannis
    Delimitsou, Angeliki
    Vodicka, Radek
    Vrtel, Radek
    Youroukos, Sotirios
    Stravopodis, Dimitrios J.
    Vlassi, Metaxia
    Astrinidis, Aristotelis
    Yannoukakos, Drakoulis
    Voutsinas, Gerassimos E.
    SCIENTIFIC REPORTS, 2017, 7
  • [44] Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations
    Rendtorff, ND
    Bjerregaard, B
    Frödin, M
    Kjaergaard, S
    Hove, H
    Skovby, F
    Brondum-Nielsen, K
    Schwartz, M
    HUMAN MUTATION, 2005, 26 (04) : 374 - 383
  • [45] Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations
    Jansen, F. E.
    Braams, O.
    Vincken, K. L.
    Algra, A.
    Anbeek, P.
    Jennekens-Schinkel, A.
    Halley, D.
    Zonnenberg, B. A.
    van den Ouweland, A.
    van Huffelen, A. C.
    van Nieuwenhuizen, O.
    Nellist, M.
    NEUROLOGY, 2008, 70 (12) : 908 - 915
  • [46] Structural investigation of multiple binding interactions with TSC1/TSC2 complex
    Adkins, Brandon C.
    Chi, Young-In
    FASEB JOURNAL, 2007, 21 (05): : A638 - A638
  • [47] The cellular response to ectopic overexpression of the tuberous sclerosis genes, TSC1 and TSC2:: A proteomic approach
    Hengstschläger, M
    Rosner, M
    Fountoulakis, M
    Lubec, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (03) : 831 - 838
  • [48] Conservation of Structural and Functional Elements of TSC1 and TSC2: A Bioinformatic Comparison Across Animal Models
    Serfontein, Jaco
    Nisbet, R. Ellen R.
    Howe, Christopher J.
    de Vries, Petrus J.
    BEHAVIOR GENETICS, 2011, 41 (03) : 349 - 356
  • [49] Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
    Tavazoie, SF
    Alvarez, VA
    Ridenour, DA
    Kwiatkowski, DJ
    Sabatini, BL
    NATURE NEUROSCIENCE, 2005, 8 (12) : 1727 - 1734
  • [50] TSC1 and TSC2 mutations in patients with lymphangioleiomyomatosis and tuberous sclerosis complex
    Muzykewicz, D. A.
    Sharma, A.
    Muse, V.
    Numis, A. L.
    Rajagopal, J.
    Thiele, E. A.
    JOURNAL OF MEDICAL GENETICS, 2009, 46 (07) : 465 - 468